Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 065630/0609 | |
| Pages: | 5 |
| | Recorded: | 11/20/2023 | | |
Attorney Dkt #: | IMM356-US-6C1 CORRECTED |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS LINE 1 OF THE CORRESPONDENCE ADDRESS ON COVER SHEET PREVIOUSLY RECORDED AT REEL: 065586 FRAME: 0323. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18473123
|
Filing Dt:
|
09/22/2023
|
Publication #:
|
|
Pub Dt:
|
05/09/2024
| | | | |
Title:
|
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY
|
|
Assignee
|
|
|
C/O GILEAD SCIENCES, INC. |
333 LAKESIDE DRIVE |
FOSTER CITY, CALIFORNIA 94404 |
|
Correspondence name and address
|
|
IMMUNOMEDICS, INC.
|
|
C/O GILEAD SCIENCES, INC.
|
|
333 LAKESIDE DRIVE
|
|
FOSTER CITY, CA 94404
|
Search Results as of:
05/29/2024 06:03 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|